In a unanimous decision, the board of directors reelected Haute 100 Miami Lister Phillip Frost for what would be his second three-year term as chairman of Teva Pharmaceutical Industries.
The recurring appointee will officially take office as the new term’s chairman in the upcoming general meeting hosted by the firm. Teva’s vice chairman, Moshe Many said, “Dr. Phillip Frost has the board’s full support. We would continue to benefit from his vision and guidance.”